Announced
McKesson to acquire Genospace from SCRI.
Synopsis
McKesson, a diversified healthcare services provider, agreed to acquire Genospace, a personalized medicine platform, from Sarah Cannon Research Institute, a clinical trials facility. Financial terms were not disclosed.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.